IL6 and cancer: By the use of species‐specific ELISAs, we also found that tumour‐bearing mice were subjected to a massive rise in the level of serum IL‐6 derived from the cancer cells (human IL‐6) (Figure4K) and a significant, but clearly less substantial, increase in host‐derived murine IL‐6 (Figure4L).